Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysis.

The Journal of international medical research - 1 May 2026

Yang Li-Rong, Li Tian-Tian, Teng Zhao-Wei, Peng Xin-Hao, Liu Yuan, Chen Li, Fan Jia

Abstract excerpt

BackgroundLung adenocarcinoma is a multifaceted disease with diverse locations and timings of gene mutations, histology, and molecular pathogenesis. Thus, identifying therapeutic target genes for lung adenocarcinoma has become a major challenge.MethodWe downloaded the gene expression profiles of 220 patients with lung adenocarcinoma from the Gene Expression Omnibus database and identified the differentially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Kaplan-Meier Estimate

Share to Lung Neoplasms

Share to Mendelian Randomization Analysis

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 42103327
DOI: 10.1177/03000605261446152
PMCID: PMC13167297

Genes

ANGPT1
CD36
POU2AF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysis.PMID 42103327Read ↗

Prognostic biomarkers for lung adenocarcinoma based on Mendelian randomization analysisSemantic proximity Read ↗

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaSemantic proximity Read ↗

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.Semantic proximity Read ↗

Biomarkers Exploration of Epithelial-Mesenchymal Transition and Ferroptosis in Lung Adenocarcinoma: Transcriptomic Analysis and Mendelian RandomizationSemantic proximity Read ↗

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read ↗

Bidirectional mendelian randomization and single-cell sequencing reveal T cell-mediated causal links between COPD and lung adenocarcinomaSemantic proximity Read ↗

Inflammatory factors and risk of lung adenocarcinoma: a Mendelian randomization study mediated by blood metabolites.Semantic proximity Read ↗

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analysesSemantic proximity Read ↗

Identification of promising lung cancer drug targets from human plasma proteins: Mendelian randomization, single-cell RNA sequencing analysisSemantic proximity Read ↗

Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis.Semantic proximity Read ↗

Pathway-based gene signatures predicting clinical outcome of lung adenocarcinomaSemantic proximity Read ↗

Druggable genome-wide Mendelian randomization integrating GWAS and eQTL/pQTL data identifies targets for lung squamous cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.